Susceptibility of Enterococcus genus to new antimicrobial agents;Sensibilidad del género Énterococcus a nuevos antimicrobianos

Revista Espanola de Quimioterapia

Volumn 17, Issue 2, 2004, Pages 184-188

  Sanchez Molina M I ^a   Martin D ^a   Valladares, C ^a   Gastanares M J ^a   Torres, C ^b   Borque, L ^a  

^a HOSPITAL SAN PEDRO   (Spain)

^b UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

Antibiotic resistance; Enterococcus spp.; Ketolide; Oxazolidinone; Streptogramin

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; JOSAMYCIN; KETOLIDE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; STREPTOGRAMIN; STREPTOMYCIN; TEICOPLANIN; TELITHROMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENETIC SUSCEPTIBILITY; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; STRAIN DIFFERENCE;

EID: 3943054853     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cormican, M.G., Jones, R.N. Emerging resistance to antimicrobial agents in grampositive bacteria. Drugs 1996; 51: 6-12.
2. Torres, C., Zarazaga, M., Tenorio, C. y cols. In vitro activity of the new ketolide HMR 3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp. Antimicrob Agents Chemother 1998; 42: 3279-3281.
3. Torres, C., Tenorio, C., Lantero, M., Gastañares, M.J., Baquero, F. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrob Agents Chemother 1993; 37: 2427-2431.
4. Cercenado, E., García-Leoni, M.E., Rodeño, P., Rodríguez-Creixems, M. Ampicillin-resistant enterococci. Antimicrob Agents Chemother 1990;28:829.
5. Tomayko, J.F., Zscheck, K.K., Singh, K.V., Murray, B.E. Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis. Antimicrob Agents Chemother 1996; 40: 1170-1174.
6. Coudron, P.E., Markowitz, S.M., Wong, E.S. Isolation of a beta-lactamase producing strain of Enterococcus faecium. Antimicrob Agents Chemother 1992; 36: 1125-1126.
7. Peset, V., Ubeda, P., Sarrión, A. y cols. Evolución de las resistencias del género Enterococcus en cepas aisladas en sangre. Rev Esp Quimioterap 1998; 11: 322-326.
8. Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martínez, J.L., Torres, C. Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother 2000; 44: 967-971.
9. Balas, D., Alós, J.I., Carvajal, R., Gómez-Garcés, J.L. Enterococos aislados en sangre (1989-1993): Evolución de la susceptibilidad a los antibióticos. Enferm Infecc Microbiol Clin 1995; 13: 445-459.
10. Balas, D., Perea, B., Wilhelmi, Y., Romanyl, J., Alós, J.I., Gómez-Garcés, J.L. Prevalencia de resistencia antimicrobiana en enterococos aislados en sangre en Madrid (1994-1995). Enferm Infecc Microbiol Clin 1996; 15: 22-23.
11. Watanakunakorn, C. Rapid increase in the prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1989-1991. J Antimicrob Chemother 1992; 30: 289-293.
12. Schouten, M.A., Voss, A., Hoogkamp-Korstanje, J.A. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrob Agents Chemother 1999; 43: 2542-2546.
13. Barry, A.L., Fuchs, P.C., Brown, S.D. Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests. J Antimicrob Chemother 2001; 48: 121-125.
14. Birmingham, M.C., Rayner, C.R., Meagher, A.K., Flavin, S.M., Batts, D.H. Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program. Clin Infect Dis 2003; 36: 159-168.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 12th Informational, Suppl. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA 2002.
16. Leroy, B., Rangaraju, M. High in vitro susceptibility of the ketolide telithromycin (HMR 3647) in clinical isolates of key respiratory pathogens. 40th Interscience Conference of Antimicrobial Agents and Chemotherapy, Toronto, Canada 2000.
17. Ruoff, K.L., Maza, L., Murtagh, M.J., Spargo, J.D., Ferrano, M.J. Species identity of enterococci isolated from clinical species. J Clin Microbiol 1990; 28: 435-437.
18. Jones, R.M., Marshall, S.A., Pfaller, M.A., Wilke, W.W., Hollis, R.J., Erwin, M.E. Nosocomial enterococal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. Diagn Microbiol Infect Dis 1997; 29: 95-102.
19. Jones, R.N., Hare, R.S., Sabatelli, F.J., Ziracin Susceptibility Testing Group. In vitro gram-positive antimicrobial activity of evernimicin (SCM 27899), a novel oligosaccharide, compared with other antimicrobial: A multicentre international trial. J Antimicrob Chemother 2001; 47: 15-25.
20. Hällgren, A., Abednazari, H., Ekdahl, C. y cols., Swedish ICU Study Group. Antimicrobial susceptibility patterns of enterococci in intensive care unit in Sweden evaluated by different MIC breakpoints systems. J Antimicrob Chemother 2001; 48: 53-62.
21. Cisterna, R., Ibarra, K., Morca, A. y cols., Grupo Español de Estudio y Vigilancia de Resistencias. Estudio multicéntrico de resistencias en enterococos. Papel de la teicoplanina. Rev Esp Quimioterap 1999; 12: 237-243.
22. Goossens, H. Spread of vancomycin-resistant enterococci: Differences between the United States and Europe. Inf Control Hosp Epidem 1998; 19: 546-551.
23. Landman, D., Quale, J.M. Management of infections due to resistant enterococci. A review of therapeutic options. J Antimicrob Chemother 1997; 40: 161-170.
24. Jhonson, A.P., Warner, M., Livermore, D.M. Activity of linezolid against multi-resistant grampositive bacteria from diverse hospital in the United Kingdom. J Antimicrob Chemother 2000; 45: 225-230.
25. Miyazaki, S., Fujikawa, T., Kobayashi, I., Matsumoto, T., Tateda, K., Yamaguchi, K. The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci. J Antimicrob Chemother 2002; 50: 971-974.